PER 0.00% 8.0¢ percheron therapeutics limited

Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-199

  1. 2,956 Posts.
    lightbulb Created with Sketch. 116
    Furthermore the results recently IMV don’t justify the current SP and a retracting one at that.
    The only common factor is MD and the lack of confidence investors have in him. Other than day traders making some quick money there appears little substance from quality investors.
    I have said it before I would be happy to be proven wrong with a kick ass announcement.....
    A move along MD would go a long way to the Co. growing and market investment. There has to be more charismatic leaders around who can bring in the investors and the market on what could be huge gains.
    Unfortunately while the MD is at the top we will flounder here forever....
    Surely the board can see this.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.9¢ $12.63K 158.7K

Buyers (Bids)

No. Vol. Price($)
2 66500 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 273231 2
View Market Depth
Last trade - 15.26pm 19/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.